Ismail Sergin is a highly skilled scientist with extensive experience in cancer research and molecular biology. Currently serving as Principal Scientist at Calico Life Sciences since September 2022, Ismail previously held the position of Principal Scientific Researcher at Genentech from May 2017 to September 2022, focusing on tumor biology, colorectal cancer, cancer immunotherapy, and Wnt signaling. Prior to this, Ismail was a Postdoctoral Researcher at Washington University in St. Louis from May 2012 to May 2017, where research concentrated on autophagy and lysosomal degradation in cardiovascular and metabolic diseases. Ismail earned a PhD in Cell/Cellular and Molecular Biology from Washington University in St. Louis and a Bachelor's degree in Molecular Biology and Genetics from Bilkent University.
This person is not in the org chart
This person is not in any teams
This person is not in any offices